Q/C Technologies Inc (QCLS)

$5.75 +0.65 (12.75%)
Market Cap 9.42M
Revenue (ttm) 0.00
Net Income (ttm) -23.36M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 8,140,600
Avg Vol 1,970,880
Day's Range N/A - N/A
Shares Out 1.85M
Stochastic %K 29%
Beta 2.06
Analysts Strong Buy
Price Target N/A

Company Profile

Q/C Technologies, Inc., a clinical-stage pharmaceutical company, focuses on developing and commercializing therapeutic platforms based on various therapeutic targets. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including sarcopenia, frailty, adverse effects of drugs used to treat diabetes and obesity, rheumatoid arthritis, and inflammatory bowel disease. It also develops Supera-CBD, a synthetic analog o...

Industry: Computer Hardware
Sector: Technology
Phone: 856 848 8698
Address:
1185 Avenue of the Americas, Suite 249, New York, United States
letuan7
letuan7 Oct. 5 at 1:27 AM
$QCLS over 6 next week highest 🤣🤣🤣🤣
0 · Reply
JJBurch
JJBurch Oct. 5 at 1:27 AM
$QCLS I’ve been saying 1000% yes Certainly very possible. Short term. They’ll sell their advanced bio assets for likely $20M+ and use that cash for crypto treasury
0 · Reply
JJBurch
JJBurch Oct. 5 at 1:26 AM
$QCLS yep
0 · Reply
davis8uni
davis8uni Oct. 5 at 1:04 AM
$TSHA $RGTI $QCLS $XELB $ASTC
0 · Reply
karahananifunds
karahananifunds Oct. 5 at 12:58 AM
$RGTI $QBTS $IONQ $QUBT $QCLS https://x.com/giacobocanegra/status/1974481088891208119?s=46
1 · Reply
Dmonday123
Dmonday123 Oct. 5 at 12:09 AM
$QCLS getting excited about this could actually be a long term investment the tech is rare. Quantum/Treasury company there are none of those.
0 · Reply
Bar239mado
Bar239mado Oct. 4 at 11:33 PM
$QCLS 1000% it’s not a dream 🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥👎👎
1 · Reply
Asrm088
Asrm088 Oct. 4 at 10:43 PM
$QCLS 10-12 incoming I think this week
1 · Reply
RM7391
RM7391 Oct. 4 at 10:29 PM
$QCLS 😮
0 · Reply
UgoGreg
UgoGreg Oct. 4 at 10:17 PM
$QCLS https://youtu.be/0nLqCWJ80FE
0 · Reply
Latest News on QCLS
Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol “QCLS”

Sep 25, 2025, 9:15 AM EDT - 9 days ago

Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol “QCLS”

TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol “QCLS” to Reflect Strategic Focus on Quantum Class Photonic Computing

Sep 24, 2025, 9:15 AM EDT - 10 days ago

TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol “QCLS” to Reflect Strategic Focus on Quantum Class Photonic Computing

TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

Sep 17, 2025, 9:24 AM EDT - 17 days ago

TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

TNF Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Sep 8, 2025, 9:15 AM EDT - 26 days ago

TNF Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

TNF Pharmaceuticals Announces Closing of $7 Million Private Placement

Sep 4, 2025, 9:15 AM EDT - 4 weeks ago

TNF Pharmaceuticals Announces Closing of $7 Million Private Placement

PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications

Sep 2, 2025, 9:20 AM EDT - 4 weeks ago

PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications

PMCB

TNF Pharmaceuticals Secures Exclusive Global Rights to Innovative Light Speed Computing Accelerator for Use in Cryptocurrency Applications

Sep 2, 2025, 9:15 AM EDT - 4 weeks ago

TNF Pharmaceuticals Secures Exclusive Global Rights to Innovative Light Speed Computing Accelerator for Use in Cryptocurrency Applications

TNF Pharmaceuticals Announces Reverse Stock Split For Nasdaq Listing Compliance

Aug 28, 2025, 9:15 AM EDT - 5 weeks ago

TNF Pharmaceuticals Announces Reverse Stock Split For Nasdaq Listing Compliance

TNF Pharmaceuticals Strengthens Financial Position for Growth and Value Creation

Aug 19, 2025, 5:20 PM EDT - 6 weeks ago

TNF Pharmaceuticals Strengthens Financial Position for Growth and Value Creation

TNF Pharmaceuticals Collaborates with DADA2 Foundation for Compassionate Use Study of Isomyosamine in Rare Pediatric Autoinflammatory Disease

Jun 24, 2025, 9:15 AM EDT - 3 months ago

TNF Pharmaceuticals Collaborates with DADA2 Foundation for Compassionate Use Study of Isomyosamine in Rare Pediatric Autoinflammatory Disease

TNF Pharmaceuticals and Renova Health Report Positive Results in Identifying Targets for Treating TNF-Driven Inflammation in Patients Receiving GLP-1 Agonists

May 8, 2025, 9:20 AM EDT - 5 months ago

TNF Pharmaceuticals and Renova Health Report Positive Results in Identifying Targets for Treating TNF-Driven Inflammation in Patients Receiving GLP-1 Agonists

TNF Pharmaceuticals and Renova Health Utilize AI to Accelerate Drug Development

Apr 22, 2025, 9:15 AM EDT - 5 months ago

TNF Pharmaceuticals and Renova Health Utilize AI to Accelerate Drug Development

TNF Pharmaceuticals Delivers Platform Presentation of Oral TNF-Alpha Inhibitor Isomyosamine at British Geriatrics Society's Spring Meeting 2025

Apr 16, 2025, 9:15 AM EDT - 6 months ago

TNF Pharmaceuticals Delivers Platform Presentation of Oral TNF-Alpha Inhibitor Isomyosamine at British Geriatrics Society's Spring Meeting 2025

TNF Pharmaceuticals Delivers Podium Presentation of Novel Oral TNF-Alpha Inhibitor at Premier International Conference on Frailty and Sarcopenia

Mar 17, 2025, 9:15 AM EDT - 7 months ago

TNF Pharmaceuticals Delivers Podium Presentation of Novel Oral TNF-Alpha Inhibitor at Premier International Conference on Frailty and Sarcopenia

TNF Pharmaceuticals to Host Investor Conference Call and Webcast Featuring Clinical Scientific Updates on Thursday, March 6, 2025

Mar 5, 2025, 9:00 AM EST - 7 months ago

TNF Pharmaceuticals to Host Investor Conference Call and Webcast Featuring Clinical Scientific Updates on Thursday, March 6, 2025

TNF Pharmaceuticals Initiates Phase 2b Clinical Trial of First Oral TNF-Alpha Inhibitor

Feb 25, 2025, 9:20 AM EST - 7 months ago

TNF Pharmaceuticals Initiates Phase 2b Clinical Trial of First Oral TNF-Alpha Inhibitor

TNF Pharmaceuticals Launches Study Series Aimed at Preserving Lean Muscle Mass During GLP-1 Weight Loss Treatment

Jan 29, 2025, 9:15 AM EST - 8 months ago

TNF Pharmaceuticals Launches Study Series Aimed at Preserving Lean Muscle Mass During GLP-1 Weight Loss Treatment

TNF Pharmaceuticals Announces Positive Clinical Data Supporting Clinical Trial Expansion

Jan 15, 2025, 9:15 AM EST - 9 months ago

TNF Pharmaceuticals Announces Positive Clinical Data Supporting Clinical Trial Expansion

TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs

Dec 19, 2024, 9:15 AM EST - 10 months ago

TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs

TNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel Sarcopenia/Frailty Treatment at Prestigious International Conference

Dec 9, 2024, 9:00 AM EST - 10 months ago

TNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel Sarcopenia/Frailty Treatment at Prestigious International Conference

TNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to Market

Oct 2, 2024, 9:10 AM EDT - 1 year ago

TNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to Market

TNF Pharmaceuticals Prepares to Advance Lead Clinical Program Targeting Age-Related Decline

Aug 21, 2024, 9:00 AM EDT - 1 year ago

TNF Pharmaceuticals Prepares to Advance Lead Clinical Program Targeting Age-Related Decline

letuan7
letuan7 Oct. 5 at 1:27 AM
$QCLS over 6 next week highest 🤣🤣🤣🤣
0 · Reply
JJBurch
JJBurch Oct. 5 at 1:27 AM
$QCLS I’ve been saying 1000% yes Certainly very possible. Short term. They’ll sell their advanced bio assets for likely $20M+ and use that cash for crypto treasury
0 · Reply
JJBurch
JJBurch Oct. 5 at 1:26 AM
$QCLS yep
0 · Reply
davis8uni
davis8uni Oct. 5 at 1:04 AM
$TSHA $RGTI $QCLS $XELB $ASTC
0 · Reply
karahananifunds
karahananifunds Oct. 5 at 12:58 AM
$RGTI $QBTS $IONQ $QUBT $QCLS https://x.com/giacobocanegra/status/1974481088891208119?s=46
1 · Reply
Dmonday123
Dmonday123 Oct. 5 at 12:09 AM
$QCLS getting excited about this could actually be a long term investment the tech is rare. Quantum/Treasury company there are none of those.
0 · Reply
Bar239mado
Bar239mado Oct. 4 at 11:33 PM
$QCLS 1000% it’s not a dream 🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥👎👎
1 · Reply
Asrm088
Asrm088 Oct. 4 at 10:43 PM
$QCLS 10-12 incoming I think this week
1 · Reply
RM7391
RM7391 Oct. 4 at 10:29 PM
$QCLS 😮
0 · Reply
UgoGreg
UgoGreg Oct. 4 at 10:17 PM
$QCLS https://youtu.be/0nLqCWJ80FE
0 · Reply
JJBurch
JJBurch Oct. 4 at 9:56 PM
$QCLS https://quantumzeitgeist.com/lightsolver-maps-pdes-onto-laser-processor-boosting-scientific-computing/
0 · Reply
JJBurch
JJBurch Oct. 4 at 9:53 PM
$QCLS https://insidehpc.com/2025/06/laser-based-hpc-computing-lightsolver-named-technology-pioneer-by-world-economic-forum/
0 · Reply
Vikingsstrade
Vikingsstrade Oct. 4 at 7:19 PM
Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve! $XELB $UPS $RDW $QCLS
0 · Reply
highnihilism
highnihilism Oct. 4 at 5:16 PM
$QCLS Q/C Technologies volume 6,578,843 | average 1,106,836 × 5.9 | price 5.75 +0.65 (+12.7%)
1 · Reply
Dat1099Boi
Dat1099Boi Oct. 4 at 2:49 PM
$QCLS $CRML Man I hate the weekend. Crypto trading is okay but nothing compares to the stock market being open, money being made and lost, unlimited potential.
2 · Reply
ProfessorDman1
ProfessorDman1 Oct. 4 at 2:45 PM
Watching Monday : $SLRX $SGBX $AREB $NCNA $QCLS
2 · Reply
davis8uni
davis8uni Oct. 4 at 2:44 PM
$TSHA $RGTI $QCLS $XELB $ASTC
0 · Reply
Jkm11
Jkm11 Oct. 4 at 2:32 PM
$QCLS ...
0 · Reply
Jkm11
Jkm11 Oct. 4 at 2:31 PM
$QCLS interesting...LPU technology developed 2020, seems to be a way to beat standard processors and significantly reduces electricity and the heat problems of giant AI super computers. I am intrigued to see where it goes given quantum stock boom.
1 · Reply
Dmonday123
Dmonday123 Oct. 4 at 1:42 PM
$QCLS treasury company incoming They will leverage the value of the Quantum tech in the deal. Pipe should come in higher than current price. As company has $7 per share in cash after selling preferreds for $1,000 per share for the additional $7M
1 · Reply
baybayy
baybayy Oct. 4 at 1:37 PM
$QCLS What’s yalls opinion , do we get a dip Monday or do we continue back up?
1 · Reply
JJBurch
JJBurch Oct. 4 at 1:10 PM
$QCLS @jaltucher I should have tagged you I’m sorry! See questions below. Thank you again for offering your honesty! Much appreciated. $TAO.X $TAOX
1 · Reply